Secondary Hypertension: The Ways of Management

被引:0
作者
Rossi, Gian Paolo [1 ]
Seccia, Teresa M. [1 ]
Pessina, Achille C. [1 ]
机构
[1] Univ Padua, Dept Clin & Expt Med Internal Med 4, I-35126 Padua, Italy
关键词
Hypertension; renin; aldosterone; angiotensin; renovascular; catecholamines; RENAL-ARTERY STENOSIS; UNILATERAL ADRENAL-HYPERPLASIA; MULTIPLE ENDOCRINE NEOPLASIA; OF-THE-ART; PRIMARY ALDOSTERONISM; RENOVASCULAR HYPERTENSION; CHROMOGRANIN-A; COMPUTED-TOMOGRAPHY; FAMILIAL PHEOCHROMOCYTOMA; EXCESS PREVALENCE;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The prevalence of secondary hypertension is lower than that of primary (essential) hypertension, but it is likely that it has been underestimated because appropriate tests were not generally performed. Hence, before embarking on a search for secondary hypertension physicians are generally advised to select populations of patients with a high pre-test probability of secondary forms of hypertension in order to maximize the positive predictive value and the gain in "ruling in" of the diagnostic tests. Based on updated information on prevalence and pathophysiology we herein critically review the general diagnostic strategy and the management of the main forms of secondary hypertension. In particular, strategies for identifying primary aldosteronism, the most frequent form of endocrine secondary hypertension, and for determining its unilateral or bilateral causes are discussed in details, because of the differences of treatment that requires adrenalectomy in the unilateral forms and mineralocorticoid receptor blockade in the bilateral forms. The tests available for the diagnosing pheochromocytoma, which is much rarer but extremely important to identify, as it can be fatal if unrecognized are also discussed, with emphasis on the recent developments in genetic testing. Renovascular hypertension is also a common curable form of hypertension, which should be identified as early as possible to avoid the onset of cardiovascular target organ damage and events, is also discussed.
引用
收藏
页码:753 / 768
页数:16
相关论文
共 90 条
  • [1] Treatment of Malignant Pheochromocytoma
    Adjalle, R.
    Plouin, P. F.
    Pacak, K.
    Lehnert, H.
    [J]. HORMONE AND METABOLIC RESEARCH, 2009, 41 (09) : 687 - 696
  • [2] Germline SDHD mutation in familial phaeochromocytoma
    Astuti, D
    Douglas, F
    Lennard, TWJ
    Aligianis, IA
    Woodward, ER
    Evans, DGR
    Eng, C
    Latif, F
    Maher, ER
    [J]. LANCET, 2001, 357 (9263) : 1181 - 1182
  • [3] Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma
    Baysal, BE
    Ferrell, RE
    Willett-Brozick, JE
    Lawrence, EC
    Myssiorek, D
    Bosch, A
    van der Mey, A
    Taschner, PEM
    Rubinstein, WS
    Myers, EN
    Richard, CW
    Cornelisse, CJ
    Devilee, P
    Devlin, B
    [J]. SCIENCE, 2000, 287 (5454) : 848 - 851
  • [4] BEARD CM, 1983, MAYO CLIN PROC, V58, P802
  • [5] PREVALENCE OF PRIMARY AND SECONDARY HYPERTENSION - STUDIES IN A RANDOM POPULATION-SAMPLE
    BERGLUND, G
    ANDERSSON, O
    WILHELMSEN, L
    [J]. BRITISH MEDICAL JOURNAL, 1976, 2 (6035) : 554 - 556
  • [6] CURRENT CONCEPTS - PHEOCHROMOCYTOMA - DIAGNOSIS, LOCALIZATION AND MANAGEMENT
    BRAVO, EL
    GIFFORD, RW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (20) : 1298 - 1303
  • [7] Pheochromocytoma: State-of-the-art and future prospects
    Bravo, EL
    Tagle, R
    [J]. ENDOCRINE REVIEWS, 2003, 24 (04) : 539 - 553
  • [8] ENDOCRINE HYPERTENSION - PREFACE
    BRAVO, EL
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1994, 23 (02) : R11 - R11
  • [9] DIAGNOSTIC SPECIFICITY OF SERUM CHROMOGRANIN-A FOR PHEOCHROMOCYTOMA IN PATIENTS WITH RENAL DYSFUNCTION
    CANALE, MP
    BRAVO, EL
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (05) : 1139 - 1144
  • [10] REACTIVE HYPERRENINEMIA IN RENOVASCULAR HYPERTENSION AFTER ANGIOTENSIN BLOCKADE WITH SARALASIN OR CONVERTING ENZYME-INHIBITOR
    CASE, DB
    LARAGH, JH
    [J]. ANNALS OF INTERNAL MEDICINE, 1979, 91 (02) : 153 - 160